Primary thrombocythemia: new drugs for an evolving disease

Thrombopoietin receptor agonists in hereditary thrombocytopenias.

Journal of thrombosis and haemostasis : JTH·2018

Extramedullary hematopoiesis: a new feature of inherited thrombocytopenias?

Journal of thrombosis and haemostasis : JTH·2017

Bleeding is not the main clinical issue in many patients with inherited thrombocytopaenias.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders.

Journal of thrombosis and haemostasis : JTH·2017

β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia.

Journal of thrombosis and haemostasis : JTH·2014

Inherited thrombocytopenias frequently diagnosed in adults.

Journal of thrombosis and haemostasis : JTH·2013

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Haematologica·2026

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Haematologica·2026

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Haematologica·2026

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Haematologica·2026

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Haematologica·2026

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Haematologica·2026

The use of the enzyme chitosanase to enable vaccine potency determination in a formulation containing the adjuvant chitosan.

Journal of pharmaceutical sciences·2026

Alterations in regional cerebral perfusion in drug-induced Parkinsonism: Spatial covariance analyses of early-phase 18F-FP-CIT PET data.

Parkinsonism & related disorders·2026

New paradigm of therapeutic antibiotic monitoring.

Casopis lekaru ceskych·2026

Improving drug therapy safety through pictograms: opportunities, limitations and future prospects-a survey of healthcare professionals.

European journal of hospital pharmacy : science and practice·2026

Formation of a pulmonary drug-depot by a double-ester treprostinil prodrug enables sustained lung-selective delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026

ETODA: Automatic three-dimensional error tolerance grid generation for dosage adaptation in precision medicine.

Computer methods and programs in biomedicine·2026

Related Experiment Videos

Primary thrombocythemia: new drugs for an evolving disease

Related Concept Videos

Thrombopoietin receptor agonists in hereditary thrombocytopenias.

Extramedullary hematopoiesis: a new feature of inherited thrombocytopenias?

Bleeding is not the main clinical issue in many patients with inherited thrombocytopaenias.

Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders.

β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia.

Inherited thrombocytopenias frequently diagnosed in adults.

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

The use of the enzyme chitosanase to enable vaccine potency determination in a formulation containing the adjuvant chitosan.

Alterations in regional cerebral perfusion in drug-induced Parkinsonism: Spatial covariance analyses of early-phase 18F-FP-CIT PET data.

New paradigm of therapeutic antibiotic monitoring.

Improving drug therapy safety through pictograms: opportunities, limitations and future prospects-a survey of healthcare professionals.

Formation of a pulmonary drug-depot by a double-ester treprostinil prodrug enables sustained lung-selective delivery.

ETODA: Automatic three-dimensional error tolerance grid generation for dosage adaptation in precision medicine.

Related Experiment Videos

Primary thrombocythemia: new drugs for an evolving disease

Related Concept Videos

Related Articles